‏1,238.00 ₪

Lung Cancer

‏1,238.00 ₪

ISBN13

9780323695732

מהדורה

1st ED

הוצאה לאור

Elsevier

זמן אספקה

21 ימי עסקים

עמודים

512

תאריך יציאה לאור

8 בדצמ׳ 2023

Care of the lung cancer patient—screening, diagnosis, and treatment—has undergone recent dramatic changes due to technologic and research-driven advances. Lung Cancer: An Evidence-Based Approach to Multidisciplinary Management covers every aspect of this fast-changing field, including new screening guidelines, new practice standards, and new treatment advances that have led to higher survival rates. This practical, clinically oriented resource provides thorough, evidence-based coverage from experts in the field, including the increasingly important precision medicine approach in lung cancer planning and management.

Key Features

Discusses key topics such as small cell and non-small cell lung cancers; immunotherapy, molecular cohorts including ROS1, BRAF, HER2, Met, and NTRK; oligometastatic disease; and more.
Covers individualized treatment plans for chemotherapy, radiotherapy, targeted biomarker-derived therapies, and new and emerging immunotherapies.
Provides excellent visual guidance throughout, including algorithms, pathology specimens, anatomic drawings, and PET/CT and CT imaging for diagnosis and treatment planning.
Features “Top 5 Clinical Pearls at the beginning of each chapter.
Shares the experience and knowledge of medical oncologists, radiation oncologists, surgical oncologists, and thoracic radiologists for a real-world tumor board perspective.
An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud.

לדלג לסוף של גלריית תמונות

לדלג להתחלה של גלריית תמונות

מידע נוסף

מידע נוסף
מהדורה	1st ED
עמודים	512
הוצאה לאור	Elsevier
תאריך יציאה לאור	8 בדצמ׳ 2023
Author	Alexis Gillaspie, MD, MPH, FACS, Leora Horn, MD, MSc, MHPE and Amanda S. Cass, PharmD
זמן אספקה	21 ימי עסקים